Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis. - Test2 - elhamkhani - TriplyDB

Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis.

Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis.

http://www.wikidata.org/entity/Q37645107

about

Suppression of asparaginyl endopeptidase attenuates breast cancer-induced bone pain through inhibition of neurotrophin receptors.Mouse Antibody of IgM Class is Prone to Non-Enzymatic Cleavage between CH1 and CH2 Domains.

P2860

Q33752135-AD4216C8-A387-46B5-9F07-BB92AAF0B8B4 Q48262427-5C28DB62-54A5-4C2A-B111-3BC077D4D6D0

P2860

Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis.

http://www.wikidata.org/entity/Q37645107

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Legumain Regulates Differentia ...... n Postmenopausal Osteoporosis.

@en

Legumain Regulates Differentia ...... n Postmenopausal Osteoporosis.

@nl

type

label

Legumain Regulates Differentia ...... n Postmenopausal Osteoporosis.

@en

Legumain Regulates Differentia ...... n Postmenopausal Osteoporosis.

@nl

prefLabel

Legumain Regulates Differentia ...... n Postmenopausal Osteoporosis.

@en

Legumain Regulates Differentia ...... n Postmenopausal Osteoporosis.

@nl

P1433

Q37645107-BECF267C-94D8-4E9C-95D5-38ECFCB82F6B

P1476

Q37645107-806E1538-3DE0-4C41-AFBA-6DE8415B179A

P2093

Q37645107-07A9CA28-32A0-4331-A871-653B9EF1B4B4

Q37645107-0FD22BDE-F437-44E7-B3D5-E8AFF8D69218

Q37645107-18371AE3-DBBB-4757-B35E-9009B3A50D6D

Q37645107-1A1EFF54-478C-4F93-B3F1-A9FD71C7C7BE

Q37645107-36E7B3CF-E900-4ABC-B430-EF4FE1F27A2A

Q37645107-3A492FBB-BFE8-4300-A605-D9632F778716

Q37645107-64873279-9F2A-46F3-8C67-1B4E40A79CE4

Q37645107-78670CF2-84FC-4643-B5FA-789D6CBDD705

Q37645107-82AF58E6-B45B-4A61-B434-2FACB64C3AB8

Q37645107-E9F47CFE-3FE9-4F66-8F57-CBD897DF39EE

P2860

Q37645107-038B5664-D926-4252-A785-0CA6C5757541

Q37645107-099F0220-DFF8-437D-B2D3-99BFAF4F6EB6

Q37645107-1694ED41-2FD9-4A46-BF83-007254CB4B90

Q37645107-1784D83E-F059-4371-8696-26E76057393E

Q37645107-23D3FF4E-C800-455B-81DE-5431A0BC2E3A

Q37645107-340E46AC-9FC8-49C4-9C59-7ADDDBC6315F

Q37645107-3AAF171A-5C96-48DC-90A6-EAED1A619C90

Q37645107-3AEE1516-A714-4FBB-ADF0-FE4F4F4293D7

Q37645107-3C2673AD-2DAD-4EE5-AB6C-C754BB8ACB24

Q37645107-43AAFB53-5C00-4CD7-9C66-275F772EBF61

P304

Q37645107-7D54E542-ECF6-4029-9879-C5FADFDBC590

P31

Q37645107-187C91F3-C746-4BEF-8DFB-64BC0946723E

P356

Q37645107-8DEE9D7C-D547-4AE1-8FDE-8D1267D5D08B

P433

Q37645107-8C1F219E-07E4-4592-BEC3-C0E071191AC3

P478

Q37645107-FB1F6AC3-1300-47BD-BBDD-AED1299C10EA

P50

Q37645107-12E494CB-F9B5-4CBF-833A-AD9EAF5E947B

Q37645107-6E501C2C-ADBA-448A-A4CE-907FB74DB340

Q37645107-9BCC11EA-7B46-48EF-BF87-74C4495185F6

Q37645107-D33E51E7-C4DB-41CD-9E18-6B3705BBCE0E

Q37645107-F89DC9BA-7A20-4F7E-979D-6B1A60B96D98

P577

Q37645107-6509342F-B2CB-4734-A516-7A847B173ADB

P698

Q37645107-AC0CC2EB-5226-40C1-9648-709EC4C632B5

P921

Q37645107-F8C05C6C-B3DA-4C97-AAC2-371F21BBD7E2

P932

Q37645107-DF06376B-C659-4175-A04B-AB00F8D5AE7E

P356

J.STEMCR.2017.01.003

P1433

Stem Cell Reports

P1476

Legumain Regulates Differentia ...... in Postmenopausal Osteoporosis

@en

P2093

Abbas Jafari

http://www.w3.org/2001/XMLSchema#string

Benno Postert

http://www.w3.org/2001/XMLSchema#string

Diyako Qanie

http://www.w3.org/2001/XMLSchema#string

Harald Thidemann Johansen

http://www.w3.org/2001/XMLSchema#string

Nicholas Ditzel

http://www.w3.org/2001/XMLSchema#string

Per Kjærsgaard-Andersen

http://www.w3.org/2001/XMLSchema#string

Rigmor Solberg

http://www.w3.org/2001/XMLSchema#string

Stuart Parsons

http://www.w3.org/2001/XMLSchema#string

Sundeep Khosla

http://www.w3.org/2001/XMLSchema#string

Thomas L Andersen

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation

Stages of embryonic development of the zebrafish

Basic components of connective tissues and extracellular matrix: elastin, fibrillin, fibulins, fibrinogen, fibronectin, laminin, tenascins and thrombospondins

Asparagine endopeptidase is required for normal kidney physiology and homeostasis

Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells

The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor.

Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase.

Osteoblast mineralization requires beta1 integrin/ICAP-1-dependent fibronectin deposition.

Identification of human asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast formation and bone resorption.

Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain

P304

373-386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.STEMCR.2017.01.003

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Basem M. Abdallah

Daniel Hesselson

Jean-Marie Delaissé

Moustapha Kassem

P577

2017-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28162997

http://www.w3.org/2001/XMLSchema#string

P921

P932

5312427

http://www.w3.org/2001/XMLSchema#string